Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...
Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...
Mamie Eisenhower – flanked by two doctors – crowns Debbie Quinn of La Porte as America’s Valentine Girl at the White House in ...
A new rat study explores lung function and placental changes in the presence of infection and inflammation. The study ...
A transradial approach for cerebral angiography was less effective than the transfemoral route in achieving an accurate diagnostic success rate.
Inhibiting GLS1 reduced high blood pressure in the right side of the heart of PAH rats and improved various measures of heart ...
Seropositive rheumatoid arthritis may be protective against the development of PAH, based on results of Mendelian randomization analyses.
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE).
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the ...
Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved ...
A couple who had to make the difficult decision to tell doctors to halt CPR on their newborn child are opening up about ...
Women are more likely to have pulmonary arterial hypertension, but men tend to have worse outcomes and worse treatment responses.